Home

Decheng Capital Global Healthcare GP, LLC

CIK 1949027 · last filed 2025-10-15

Decheng Capital Global Healthcare GP, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2024. The most recent filing shows the insider sold $1.8M of BYSI on Oct 15, 2025. Across all open-market trades the lifetime net is +$128.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $372.0M across reported positions. The firm reports its address in Grand Cayman, E9. 24 SEC filings were submitted jointly with Decheng Capital Global Healthcare Fund (Master), LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$371.98M

Companies

3

Total Filings

5

Lifetime Open-Market Net

$128.92M

Filer Profile

Reported Address
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN, E9 KY1-1104
Phone
(345) 949-8066
State of Incorporation
Cayman Islands
Related Filers
Decheng Capital Global Healthcare Fund (Master), LP — 24 joint filings, latest 2025-10-20
Xiangmin Cui — 23 joint filings, latest 2025-10-20
Decheng Capital China Life Sciences USD Fund III, L.P. — 19 joint filings, latest 2025-10-20
Decheng Capital Management III (Cayman), LLC — 19 joint filings, latest 2025-10-20
Decheng Capital China Life Sciences USD Fund II, L.P. — 18 joint filings, latest 2025-10-20
Decheng Capital Global Life Sciences Fund IV, L.P. — 4 joint filings, latest 2025-02-19
Blantyre Fund III (GP) Ltd — same reported address
Target Global Sponsor Ltd. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BYSI 10%+ Owner 1,617,409 $0.76 $1.24M -$9.08M 3 2025-10-15
AARD 10%+ Owner 2,333,887 $5.13 $11.97M $100.00M 1 2025-02-19
CGON 10%+ Owner 4,958,810 $72.35 $358.77M $38.00M 1 2024-04-09

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-10-15 BYSI Sell (S) −1,076,712 -$1.81M EDGAR
2025-08-28 BYSI Sell (S) −24,654 -$44.1K EDGAR
2025-08-11 BYSI Sell (S) −2,366,616 -$7.22M EDGAR
2025-02-19 AARD Mixed +19,586,495 $100.00M EDGAR
2024-04-09 CGON Buy (P) +2,000,000 $38.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.